Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
416
datasets available to search
ShareScore release 0.9.0
Dataset results
416 results for “introns”
SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002)
ClinicalTrials.gov study NCT03552549. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Riba
ClinicalTrials.gov study NCT00160251. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
ClinicalTrials.gov study NCT00581425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects
ClinicalTrials.gov study NCT00299936. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Adjuvant PEG Intron in Ulcerated Melanoma
ClinicalTrials.gov study NCT01502696. IPD Sharing: Not stated. Countries: 12. Publications: 0.
A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00323505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
ClinicalTrials.gov study NCT00005012. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin
ClinicalTrials.gov study NCT01025765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)
ClinicalTrials.gov study NCT00255008. IPD Sharing: YES. Countries: 0. Publications: 0.
36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8
ClinicalTrials.gov study NCT01683786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)
ClinicalTrials.gov study NCT00202839. IPD Sharing: YES. Countries: 0. Publications: 0.
Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)
ClinicalTrials.gov study NCT03547154. IPD Sharing: Not stated. Countries: 0. Publications: 0.
CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00574730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)
ClinicalTrials.gov study NCT00749684. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children
ClinicalTrials.gov study NCT00006325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RegSNPs-intron: a computational framework for predicting pathogenic impact of intronic single nucleotide variants
GEO Series GSE138130. Homo sapiens; synthetic construct. 20 samples. Type: Other.
High-purity circular RNA isolation method (RPAD) reveals vast collection of intronic circRNAs (IcircRNAs)
GEO Series GSE92632. Homo sapiens; Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
An aberrant cytoplasmic intron retention programme is a blueprint for ALS-related RBP mislocalization
GEO Series GSE152983. Homo sapiens. 288 samples. Type: Expression profiling by high throughput sequencing.
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage
GEO Series GSE87281. Homo sapiens; Mus musculus. 101 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations (RCC malignancy)
GEO Series GSE40911. Homo sapiens. 44 samples. Type: Non-coding RNA profiling by array; Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.